Skip to Content

Willow Biosciences Inc CANSF

Morningstar Rating
$0.08 +0.01 (8.64%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CANSF is trading at a 471% premium.
Price
$0.08
Fair Value
$6.69
Uncertainty
Extreme
1-Star Price
$7.93
5-Star Price
$1.92
Economic Moat
Wfxqw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CANSF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.07
Day Range
$0.080.08
52-Week Range
$0.050.11
Bid/Ask
$0.08 / $0.08
Market Cap
$9.92 Mil
Volume/Avg
29,998 / 19,651

Key Statistics

Price/Earnings (Normalized)
Price/Sales
13.83
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. It has a geographic presence in Canada and the United states, in which it generates the majority of its revenue from the United states.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
33

Valuation

Metric
CANSF
Price/Earnings (Normalized)
Price/Book Value
8.92
Price/Sales
13.83
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
CANSF
Quick Ratio
1.07
Current Ratio
1.42
Interest Coverage
Quick Ratio
CANSF

Profitability

Metric
CANSF
Return on Assets (Normalized)
−120.31%
Return on Equity (Normalized)
−174.49%
Return on Invested Capital (Normalized)
−136.92%
Return on Assets
CANSF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
MvlnfmdlvzYzzrj$77.8 Bil
Zoetis Inc Class A
ZTS
DkksllzpYkwjm$76.7 Bil
Haleon PLC ADR
HLN
GtttkcjWfz$38.2 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
YdqjqtppvYkfp$19.4 Bil
Viatris Inc
VTRS
ZhtyxlljFtd$12.2 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
ZgvhbnyrdNck$11.9 Bil
Catalent Inc
CTLT
KvcphbjjLjmcpsy$9.9 Bil
Perrigo Co PLC
PRGO
KkcvmwbgrCcl$3.5 Bil
Prestige Consumer Healthcare Inc
PBH
FvyzjpzyJlrjzvn$3.3 Bil
Curaleaf Holdings Inc
CURLF
HjttnkvYtkx$3.0 Bil

Sponsor Center